Novartis plans 427 layoffs in New Jersey as looming Entresto patent cliff sparks marketing refresh

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to tighten its belt in anticipation of a generic heart med incursion later this year.